Aquestive Therapeutics (AQST) Retained Earnings (2018 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Retained Earnings of $420.9 million for Q1 2026, up 29.45% year-over-year from $325.1 million in Q1 2025, and up 1.85% quarter-over-quarter from $413.2 million in Q4 2025.
Aquestive Therapeutics (AQST) Retained Earnings (2018 - 2026) Analysis & Trends
Aquestive Therapeutics' Retained Earnings history runs 9 years deep, the most recent figure standing at $420.9 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 29.45% year-over-year to $420.9 million; the TTM figure through Mar 2026 stood at $420.9 million (up 29.45% YoY), while the FY2025 annual figure was $413.2 million, up 36.39% from the prior year.
- Retained Earnings for Q1 2026 stood at $420.9 million, up from $413.2 million in the prior quarter.
- The five-year high for Retained Earnings was $420.9 million in Q1 2026, with the low at -$415.1 million in Q3 2025.
- The 5-year median for Retained Earnings is -$286.3 million (2022), against an average of -$39.0 million.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings tumbled 271.43% in 2023, then surged 197.95% in 2025.
- Aquestive Therapeutics' Retained Earnings stood at -$311.2 million in 2022, then slipped by 2.53% to -$319.1 million in 2023, then jumped by 194.95% to $303.0 million in 2024, then jumped by 36.39% to $413.2 million in 2025, then increased by 1.85% to $420.9 million in 2026.
- Business Quant data shows AQST's Retained Earnings at $420.9 million in Q1 2026, $413.2 million in Q4 2025, and -$415.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 3.75 Bn |
| 10 | Aquestive Therapeutics | 554.35 Mn | 554.35 Mn | 9.80 Mn | -477.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -477.92 Mn |
| Mar 31, 2026 | 420.88 Mn |
| Dec 31, 2025 | 413.21 Mn |
| Sep 30, 2025 | -415.14 Mn |
| Jun 30, 2025 | -399.69 Mn |
| Mar 31, 2025 | 325.12 Mn |
| Dec 31, 2024 | 302.97 Mn |
| Sep 30, 2024 | -346.16 Mn |
| Jun 30, 2024 | 299.08 Mn |
| Mar 31, 2024 | -331.91 Mn |
| Dec 31, 2023 | -319.08 Mn |
| Sep 30, 2023 | 207.97 Mn |
| Jun 30, 2023 | 202.22 Mn |
| Mar 31, 2023 | -303.14 Mn |
| Dec 31, 2022 | -311.21 Mn |
| Sep 30, 2022 | -298.86 Mn |
| Jun 30, 2022 | -286.32 Mn |
| Mar 31, 2022 | 176.83 Mn |
| Dec 31, 2021 | -256.80 Mn |
| Sep 30, 2021 | -227.85 Mn |